ECM
CNTB

ExodusPoint Capital Management’s Connect Biopharma Holdings CNTB Stock Holding History

ExodusPoint Capital Management’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-19,400
Closed -$470K – 2213
2021
Q3 		$470K Buy
+19,400
New +$439K 0.01% 1434

Other funds holding CNTB

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

ExodusPoint Capital Management's CNTB Position: Q4 2021 in Review

ExodusPoint Capital Management sold out of Connect Biopharma Holdings (CNTB) in Q4 2021, closing a stake of 19,400 shares — an estimated $470K sold.

ExodusPoint Capital Management first reported a position in CNTB in Q3 2021 and held it in 1 quarter. The position peaked at $470K in Q3 2021. 29 funds tracked by Wall St. Rank hold CNTB as of Q4 2021.

  • ExodusPoint Capital Management reported no remaining Connect Biopharma Holdings position as of Q4 2021 after selling out during the quarter.
  • ExodusPoint Capital Management sold 19,400 Connect Biopharma Holdings shares in Q4 2021, an estimated $470K.
  • ExodusPoint Capital Management first reported a position in Connect Biopharma Holdings in Q3 2021 and held it in 1 quarter.
  • ExodusPoint Capital Management's Connect Biopharma Holdings position peaked at $470K in Q3 2021.
  • 29 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q4 2021.

Based on ExodusPoint Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.